TABLE 3.

Neonatal Antimicrobial Stewardship Targets and Proposed SAAR Antimicrobial Agent Categories

Neonatal ASP Target	SAAR Agent Category	Antimicrobials Included	Routes of Administration	NHSN Units Included
Empiric treatment of late-onset sepsis	Vancomycin	Vancomycin	IV	II, II-III, III
Broad spectrum treatment of bacterial infections	Broad spectrum antibacterial agents	Piperacillin and/or tazobactam	IV	II, II-III, III
		Cefepime
		Ertapenem
		Meropenem
		Imipenem and/or cilastatin
Prophylaxis and treatment of invasive candidiasis	Fluconazole	Fluconazole	IV, oral	II, II-III, III
Global or total antibiotic use	All antibacterial agents	All antibacterial agents in AU option	IV, IM, oral, respiratory	II, II-III, III
Empiric treatment of early-onset sepsis	Ampicillin	Ampicillin	IV	All
	Cefotaxime,Ceftazidime	Cefotaxime	IV	All
		Ceftazidime
Empiric treatment of early-onset and late-onset sepsis	Aminoglycosides	Gentamicin	IV	All
		Tobramycin
		Amikacin

IM, intramuscular; IV, intravenous.